Generic Drug Liability: Harvard Researchers Propose New Adverse Events Database, Compensation Fund

Jerry Avorn and his colleagues suggest that a new database be created at FDA to be managed by the agency’s Sentinel program, PCORI or another organization; they also recommend development of a “consensus label” and a minimum Rx fee to fund pharmacovigilance.